Compare HAYW & HTFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HAYW | HTFL |
|---|---|---|
| Founded | 1925 | 2007 |
| Country | United States | United States |
| Employees | N/A | 843 |
| Industry | Electronic Components | |
| Sector | Technology | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 2.5B |
| IPO Year | 2021 | N/A |
| Metric | HAYW | HTFL |
|---|---|---|
| Price | $13.85 | $29.53 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 5 |
| Target Price | $17.50 | ★ $38.20 |
| AVG Volume (30 Days) | ★ 2.8M | 1.0M |
| Earning Date | 04-29-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 25.93 | N/A |
| EPS | ★ 0.11 | N/A |
| Revenue | ★ $1,122,155,000.00 | N/A |
| Revenue This Year | $6.22 | $27.66 |
| Revenue Next Year | $5.96 | $23.55 |
| P/E Ratio | $123.77 | ★ N/A |
| Revenue Growth | ★ 6.71 | N/A |
| 52 Week Low | $12.93 | $20.13 |
| 52 Week High | $17.73 | $41.22 |
| Indicator | HAYW | HTFL |
|---|---|---|
| Relative Strength Index (RSI) | 43.61 | 52.34 |
| Support Level | $13.04 | $28.60 |
| Resistance Level | $16.63 | $32.71 |
| Average True Range (ATR) | 0.41 | 1.92 |
| MACD | -0.08 | -0.25 |
| Stochastic Oscillator | 38.25 | 62.61 |
Hayward Holdings is a leading manufacturer of energy-efficient swimming pool equipment and pool automation systems. The company offers a wide range of pool equipment, including pumps, filters, heaters, LED lights, and sanitization. Headquartered in Charlotte, North Carolina, the company has around 2,000 full-time employees. Hayward generated approximately $1.1 billion in revenue in 2025.
HeartFlow Inc is a commercial-stage medical technology company that provides software and artificial intelligence (AI) designed to deliver a non-invasive solution for diagnosing and managing coronary artery disease. The company operates and manages its business as a single reportable operating segment: non-invasive coronary artery disease detection solutions. Geographically, it operates in the United States and the rest of Europe, deriving the majority of its revenue from the United States. The company has developed three software products: Heartflow Roadmap Analysis, Heartflow FFRCT Analysis, and Heartflow Plaque Analysis.